Abstract:Background . Pancreatic cancer (PC) is a deadly disease with poor prognosis in the general population. We aimed to quantitate overall survival of patients with PC after irreversible electroporation (IRE) and the incidence of relevant complications. Methods . We performed a literature search via five electronic databases (PubMed, Embase, Web of Science, Scopus, and Cochrane Library databases) up to August 2017. The primary outcomes were overall survival and prognosis. Secondary outcomes included the response of post-IRE complications. Fixed-effects or random-effects meta-analysis was conducted to pool these data. Results . A total of 15 eligible articles involving 535 patients were included. The primary outcomes showed that the pooled prevalence estimates of overall survival were 94.1% (95% CI: 90.7–97.5), 80.9% (95% CI: 72.5–89.4), 54.5% (95% CI: 38.3–70.6), and 33.8% (95% CI: 14.2–53.5) at 3, 6, 12, and 24 months, and the pooled prevalence data of complete response (CR) at 2 months, partial response (PR) at 3 months, and progression at 3 months were 12.5% (95% CI: 2.9–22.2), 48.5% (95% CI: 39.4–57.6), and 19.7% (95% CI: 7.3–32.2), respectively. The secondary outcomes showed that the pooled prevalence values of post-IRE complications were abscess 6.6% (95% CI: 0.2–13), fistula 10.6% (95% CI: 2.5–18.7), pain 33.5% (95% CI: 14.5–52.5), infection 16.1% (95% CI: 3.9–28.4), thrombosis 4.9% (95% CI: 1.2–8.5), pancreatitis 7.2% (95% CI: 3.1–11.2), bleeding 4.2% (95% CI: −0.5–8.9), cholangitis 4.2% (95% CI: −0.5–8.9), nausea 9.6% (95% CI: 4.4–14.8), biliary obstruction 13.8% (95% CI: 4.2–23.3), chest tightness 7.6% (95% CI: 0.5–14.6), and hypoglycemia 5.9% (95% CI: −0.4–12.2). Conclusions . This meta-analysis indicated a clear survival benefit for PC patients who received irreversible electroporation therapy, although future safety and effectivity monitoring from more large-scale studies will be needed.

System Analysis of Clinical Application of Irreversible Electroporation for Pancreatic Cancer

Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers

Ablation Of Hepatic Malignant Tumors With Irreversible Electroporation: A Systematic Review And Meta-Analysis Of Outcomes

The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy

Irreversible Electroporation in Patients with Pancreatic Cancer: How Important Is the New Weapon?

Clinical efficacy and safety of irreversible electroporation combined with chemotherapy in stage IV pancreatic cancer treatment

Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer

Safety and Efficacy of Irreversible Electroporation in Locally Advanced Pancreatic Cancer: An Evaluation from a Surgeon's Perspective

Integrative Omics Analyses Reveal Molecular Changes of Irreversible Electroporation on Pancreatic cancer in Mice

Histological analysis of human pancreatic carcinoma following irreversible electroporation in a nude mouse model

Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer

The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma.

Irreversible electroporation stimulates a pro-inflammatory tumor microenvironment in pancreatic cancer

Irreversible Electroporation Therapy in the Management of Locally Advanced Pancreatic Adenocarcinoma

Chinese Expert Consensus on Open Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer (Version 2023)

Preliminary clinical application of the robot‐assisted CT‐guided irreversible electroporation ablation for the treatment of pancreatic head carcinoma

Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer

Safety of Irreversible Electroporation Ablation of the Pancreas

Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Irreversible electroporation and the pancreas: What we know and where we are going?

Irreversible electroporation in the treatment of locally advanced pancreas and liver metastases of colorectal carcinoma